Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions

OBJECTIVES: High dose of intravenous sulfamethoxazole and trimethoprim (co-trimoxazole) is often used in immunocompromised patients for the treatment of Pneumocystis jiroveci pneumonia. Current manufacturer’s dilution recommendation for intravenous co-trimoxazole (1:25 v/v) requires the administrati...

全面介紹

Na minha lista:
書目詳細資料
發表在:Eur J Hosp Pharm
Main Authors: Khaleel, Israa, Zaidi, Syed Tabish R, Shastri, Madhur D, Eapen, Mathew Suji, Ming, Long Chiau, Wanandy, Troy, Patel, Rahul P
格式: Artigo
語言:Inglês
出版: BMJ Publishing Group 2018
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6319416/
https://ncbi.nlm.nih.gov/pubmed/31157078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2017-001225
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍